Personalized treatment for severe breathing failure
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests two different medicines to see which one helps patients with severe breathing failure in the hospital. It aims to find the best treatment for each patient based on their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the hospital because your lungs are failing and you need extra oxygen or a breathing machine.
- Your doctor has diagnosed you with a lung condition called ARDS or a similar pandemic-related syndrome.
- You have not been on this kind of treatment for more than 48 hours.
- You are not pregnant and do not have certain other medical conditions like severe liver or kidney problems.
- You are not already taking certain medicines that could interfere with the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests a new way of setting the breathing machine for people with a lung condition called ARDS. It may help improve breathing and recovery compared to standard care.
This trial tests if bevacizumab can help people with ARDS (a serious lung condition) breathe better. It is for patients with mild, moderate, or severe ARDS who are already in the hospital.
This trial tests a new breathing machine method (called time-controlled adaptive ventilation) to see if it helps people with severe lung injury from pneumonia recover better than standard care. If you are already on a ventilator in the ICU, this study may help you breathe more easily while your lungs heal.
This trial tests a new medicine called GKL-006RTU for people with moderate to severe ARDS caused by an infection. The goal is to see if it is safe and helps improve breathing and recovery.
This study compares a more careful ventilation approach for people with severe lung breathing failure (ARDS). It aims to improve outcomes by using a specific strategy for how the ventilator controls breathing.
Hear when a new Acute Hypoxic Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.